Skip to content
Lower risk Drug recall · FDA · Published March 11, 2025

FDC Limited recalls Ciprofloxacin Ophthalmic Solution: Cap stuck in nozzle

FDC Limited recalls 5mL Ciprofloxacin Ophthalmic Solution bottles due to cap stuck in nozzle. Rx only product with specific lot number. Contact for return instructions.

🇺🇸 FDA recall #D-0282-2025DrugFDC Limited ›
Take action

Contact the company

Recalling firmFDC LimitedB-8 MIDC Industrial Area, Waluj District · Aurangabad, Maharashtra State, India
✎ GovInfoNow plain-language explainer

FDC Limited is recalling 5mL Ciprofloxacin Ophthalmic Solution bottles because the cap can get stuck in the nozzle, making it impossible to use the solution. This affects people who need prescription eye drops and could lead to improper medication use. Read more at govinfonow.com/recall/32228-fdc-limited-recalls-ciprofloxacin-ophthalmic-solution-cap-stuck-in-nozzle.

Source Summary by GovInfoNow · govinfonow.com/recall/32228-fdc-limited-recalls-ciprofloxacin-ophthalmic-solution-cap-stuck-in-nozzle · Updated August 17, 2026 · FDA enforcement record: FDA #D-0282-2025

Cite this page

“FDC Limited recalls Ciprofloxacin Ophthalmic Solution: Cap stuck in nozzle.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32228-fdc-limited-recalls-ciprofloxacin-ophthalmic-solution-cap-stuck-in-nozzle. Based on FDA recall #D-0282-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0282-2025%22&limit=1).

The FDA announced on March 11, 2025, that FDC Limited is recalling Ciprofloxacin Ophthalmic Solution USP, 0.3% in 5 mL bottles due to a defective container hazard. The agency stated the cap's spike may become lodged in the nozzle, preventing the solution from being dispensed.

How to tell if you have it

  • Brand: FDC Limited
  • Product: Ciprofloxacin Ophthalmic Solution USP, 0.3% as base
  • Package: 5 mL bottles
  • NDC: 69315-308-05
  • Lot code: 084A067
  • Expiration date: 12/31/2025
  • Distributed by: Leading Pharma LLC, Fairfield, NJ
  • Distribution: Nationwide in the U.S.
  • Units affected: 90,960 bottles

The hazard

The recall involves a defective container where the spike of the cap is lodged in the nozzle of the product bottle. This defect makes it impossible to get the solution out of the bottle.

Context

GovInfoNow's records show FDC Limited has issued 10 other recalls since April 25, 2024. Recent similar recalls include a July 5, 2025 recall for Timolol Ophthalmic Solution 0.5% and an April 18, 2025 recall for Timolol Ophthalmic Solution 10mL, both citing defective containers where the cap spike lodged in the nozzle. Other recent recalls of similar products include a July 22, 2026 recall for Micro Labs Dorzolamide/Timolol Eye Drops and a March 3, 2026 recall for K.C. Pharmaceuticals Sterile Eye Drops AC.

How to tell if you have this one

Check for the 5mL bottle labeled 'Ciprofloxacin Ophthalmic Solution USP 0.3%'. Look for the lot number 084A067 on the bottle. This product was distributed by Leading Pharma and manufactured by FDC Limited in India.

  • Brand
    FDC Limited
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Bottle Details

    Look for the lot number 084A067 on the bottle to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 15 days after the firm started it.

1. Firm started the recall: Mar 11, 202512. FDA classified it Class II: Mar 17, 202523. Published in FDA’s Enforcement Report: Mar 26, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0282-2025 (March 11, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0282-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA